Evidence map›Paper›PMID 20541129›Full record

ArticleJournal of bioscience and bioengineering2010

Improvement and induction property of radiation-responsive promoter through DNA shuffling of 5'-flanking regions of the human p21 gene.

Go Kagiya, Ryohei Ogawa, John A Cook, Rajani Choudhuri, Masanori Hatashita, Yoshikazu Tanaka, Bill G DeGraff, James B Mitchell

Open access · greenAbstract read
In one paragraph

Article in Journal of bioscience and bioengineering, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Go KagiyaSchool of Allied Health Sciences, Kitasato University, 1-15-1 Sagamihara, Kanagawa 228-8555, Japan.
Ryohei Ogawa
John A Cook
Rajani Choudhuri
Masanori Hatashita
Yoshikazu Tanaka
Bill G DeGraff
James B Mitchell
National Cancer Institute · USFoundation Wakasa Wan Energy Research Center · JPNational Institutes of Health · USUniversity of Toyama · JP

Funding

Modulation of Therapeutic ResponseZIASC006321 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI MITCHELL, JAMES · 2009 to 2025
$17.3M
MODULATION OF THERAPEUTIC RESPONSEZ01SC006321 · SC · DIVISION OF CLINICAL SCIENCES - NCI · PI MITCHELL, JAMES B · 1996 to 2008
$1.1M
Intramural NIH HHS Z01 SC006321
6 · The paper itself

Abstract

A promoter that augments gene expression in response to stimulation of ionizing radiation would be a desired tool for radiogenetic therapy, a combination of radiotherapy and gene therapy. Although various promoters occurring naturally or artificially have been used for researches, one showing higher reactivity to ionizing radiation is desirable. In the present study, we attempted to improve a radiation-responsive promoter of the p21 through a technique called DNA shuffling. A library of DNA fragments was constructed by re-ligation of randomly digested promoter fragments and improved promoters were chosen out of the library. We repeated this process twice to obtain a promoter showing 2.6-fold better reactivity to ionizing radiation compared with its parent, p21 promoter after 10 Gy gamma-ray irradiation. Nucleotide sequence analyses revealed that the obtained promoter was densely packed with some of the cis-acting elements including binding sites for p53, NF-kappaB, NRF-2, AP-1 and NF-Y more than p21 promoter. In addition, it was shown that its induction by ionizing radiation was dependent upon p53 status of a cell line, suggesting that the promoter retained properties of the p21 promoter. This technique is simple and efficient to improve a promoter responsive to other stimulus of interest besides IR.

Indexed as

Radiation, Ionizing5' Flanking RegionBase SequenceCell Line, TumorCyclin-Dependent Kinase Inhibitor p21DNA, RecombinantHeLa CellsHT29 CellsHumansMolecular Sequence DataNF-kappa BPromoter Regions, GeneticSequence AlignmentTranscription Factor AP-1Tumor Suppressor Protein p53CDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21DNA, RecombinantNF-kappa BTranscription Factor AP-1Tumor Suppressor Protein p53

Identifiers

PMID20541129
PMCPMC2886279
OpenAlexW1983152928

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.